Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy

Journal of Bone and Joint Surgery

Volumn 91, Issue 11, 2009, Pages 2556-2561

  Kumar, N ^b   Tejwani, Nirmal C ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b ARMY HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM; VITAMIN D;

ADULT; AGED; ARTICLE; BONE RADIOGRAPHY; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; DIAPHYSIS; FALLING; FEMALE; FEMUR FRACTURE; FEMUR NECK FRACTURE; FEMUR SUBTROCHANTERIC FRACTURE; FRACTURE IMMOBILIZATION; HUMAN; INTRAMEDULLARY NAILING; LONG TERM CARE; OSTEOSYNTHESIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROPHYLAXIS; RADIODIAGNOSIS; RETROSPECTIVE STUDY; STRESS FRACTURE; VITAMIN BLOOD LEVEL;

AGED; ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; FEMALE; FEMORAL FRACTURES; HUMANS; MIDDLE AGED; MULTIPLE TRAUMA; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 70449901284     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/JBJS.H.01774     Document Type: Article

References (24)

1. Pols HA, Felsenberg D, Hanley DA, Stepán J, Muñoz-Torres M, Wilkin TJ, Qin-sheng G, Galich AM, Vandormael K, Yates AJ, Stych B. Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group. Osteoporos Int. 1999;9:461-468
2. Ensrud KE, Barrett-Connor EL, Schwartz A, Santora AC, Bauer DC, Suryawanshi S, Feldstein A, Haskell WL, Hochberg MC, Torner LC, Lombardi A, Black DM; Fracture Intervention Trial Long-Term Extension Research Group. Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension. J Bone Miner Res. 2004;19:1259-1269
3. Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, Nevitt MC, Suryawanshi S, Cummings SR; Fracture Intervention Trial. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab. 2000;85:4118-4124
4. Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH, Rodriquez-Portales J, Downs RW Jr, Dequeker J, Favus M. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995;333:1437-1443
5. U.S. Food and Drug Administration. Drugs @ FDA. http://www.fda.gov/ forHealthProfessionals/Drugs/default.htm. Accessed 2009 Apr 7.
6. Li J, Mashiba T, Burr DB. Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage. Calcif Tissue Int. 2001;69:281-286 (Pubitemid 33140938)
7. Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res. 2000;15:613-620 (Pubitemid 30174014)
8. Mashiba T, Turner CH, Hirano T, Forwood MR, Johnston CC, Burr DB. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone. 2001;28:524-531 (Pubitemid 32416465)
9. Ciarelli TE, Fyhrie DP, Parfitt AM. Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. Bone. 2003;32:311-315
10. Boivin GY, Chavassieux PM, Santora AC, Yates J, Meunier PJ. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone. 2000;27:687-694 (Pubitemid 30808808)
11. Goh SK, Yang KY, Koh JS, Wong MK, Chua SY, Chua DT, Howe TS. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br. 2007;89:349-353 (Pubitemid 46563912)
12. Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury. 2008;39:224-231
13. Lenart BA, Lorich DG, Lane JM. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med. 2008;358:1304-1306
14. Lenart BA, Neviaser AS, Lyman S, Chang CC, Edobor-Osula F, Steele B, van der Meulen MC, Lorich DG, Lane JM. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int. 2009;20: 1353-1362
15. Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008;22:346-350 (Pubitemid 351630250)
16. Cheung RK, Leung KK, Lee KC, Chow TC. Sequential non-traumatic femoral shaft fractures in a patient on long-term alendronate. Hong Kong Med J. 2007;13:485-489
17. AO Foundation. Müller AO classification of fractures. http://www.aofoundation. org/wps/portal/Home. Accessed 2009 Apr 7.
18. [No authors listed]. Clinical management guidelines for osteoporosis in Hong Kong. The working group for formulating clinical management guidelines for osteoporosis in Hong Kong. Hong Kong Med J. 1998;4:423-431
19. Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005;90:1294-1301 (Pubitemid 40463979)
20. Stepan JJ, Burr DB, Pavo I, Sipos A, Michalska D, Li J, Fahrleitner-Pammer A, Petto H, Westmore M, Michalsky D, Sato M, Dobnig H. Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis. Bone. 2007;41:378-385 (Pubitemid 47199146)
21. Wu CC, Shih CH. Simultaneous bilateral femoral shaft fractures. J Trauma. 1992;32:289-293
22. Nork SE, Agel J, Russell GV, Mills WJ, Holt S, Routt ML, Jr. Mortality after reamed intramedullary nailing of bilateral femur fractures. Clin Orthop Relat Res. 2003;415:272-278
23. Kane RS, Hensleigh KA, Burns EA. Bilateral pathologic femoral shaft fractures. J Trauma. 2005;58:395-397
24. Visekruna M, Wilson D, McKiernan FE. Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab. 2008;93:2948-2952